Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Interferon”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT05005637
What this trial is testing

The Effectivity of Anti Tuberculosis Therapy in Idiopathic Uveitis with Positive IGRA

Who this might be right for
Tuberculous Uveitis
Fakultas Kedokteran Universitas Indonesia 78
Large-scale testing (Phase 3)Study completedNCT02845843
What this trial is testing

MERS-CoV Infection tReated With A Combination of Lopinavir /Ritonavir and Interferon Beta-1b

Who this might be right for
Middle East Respiratory Syndrome Coronavirus (MERS-CoV)
King Abdullah International Medical Research Center 95
Testing effectiveness (Phase 2)Study completedNCT00947349
What this trial is testing

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 201335 as Softgel Capsule in Naive Hepatitis C Virus (HCV) Patients

Who this might be right for
Hepatitis CPharmacokinetics
Boehringer Ingelheim 22
Post-approval studies (Phase 4)UnknownNCT02460133
What this trial is testing

Understanding HCV Reinfection Rates in an Incarcerated Population After Cure With Interferon Free HCV Treatment

Who this might be right for
Hepatitis C Virus
Nova Scotia Health Authority 44
Large-scale testing (Phase 3)Ended earlyNCT01459913
What this trial is testing

Efficacy of a 12-Week Regimen of Telaprevir, Pegylated Interferon, and Ribavirin in Treatment-Naive and Prior Relapser Subjects With Interleukin28B (IL28B) CC Genotype

Who this might be right for
Hepatitis C, Chronic
Vertex Pharmaceuticals Incorporated 239
Testing effectiveness (Phase 2)Study completedNCT04676724
What this trial is testing

Study of Sequential GSK3228836 and Peginterferon Treatment in Participants With Chronic Hepatitis B (CHB)

Who this might be right for
Hepatitis B
GlaxoSmithKline 108
Post-approval studies (Phase 4)Study completedNCT00915460
What this trial is testing

Open-Label Safety Extension Study of Avonex

Who this might be right for
Multiple Sclerosis
Biogen 408
Testing effectiveness (Phase 2)Study completedNCT01025596
What this trial is testing

Dose Escalation Study of IL-7 and Bi-therapy in HCV Patients Resistant After 12 Weeks of Bi-therapy (ECLIPSE 1)

Who this might be right for
Hepatitis C
Cytheris SA 10
Testing effectiveness (Phase 2)Study completedNCT00660270
What this trial is testing

Chemotherapy and Radiation Following Pancreatic Surgery

Who this might be right for
Pancreatic Cancer
Washington University School of Medicine 53
Large-scale testing (Phase 3)Study completedNCT00472797
What this trial is testing

Rebif New Formulation (RNF) Quality of Life (QOL) Study

Who this might be right for
Relapsing Multiple Sclerosis
EMD Serono 232
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07449286
What this trial is testing

IFN-α in Relapse Prevention.

Who this might be right for
Acute Myeloid LeukemiaMyelodysplastic Syndromes
Peking University People's Hospital 100
Large-scale testing (Phase 3)Study completedNCT00110396
What this trial is testing

Rebif New Formulation (RNF) in Relapsing Forms of Multiple Sclerosis

Who this might be right for
Multiple Sclerosis
EMD Serono 260
Testing effectiveness (Phase 2)Study completedNCT00250796
What this trial is testing

Trial of Thalidomide, a- Interferon +/- Octreotide in Patients With Unresectable Hepatocellular Carcinoma

Who this might be right for
LiverCancer
University of New Mexico 12
Not applicableStudy completedNCT01490853
What this trial is testing

Follow-up of Ph+ Chronic Myleoid Leukemia Patients in Complete Cytogenetic Response With Interferon Based Therapy

Who this might be right for
Chronic Myeloid Leukemia
Università degli Studi di Brescia 116
Testing effectiveness (Phase 2)Ended earlyNCT01134627
What this trial is testing

Minocycline as add-on to Interferon Beta-1a [IFN Beta-1a] (Rebif®) in Relapsing-Remitting Multiple Sclerosis [RRMS]

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Merck KGaA, Darmstadt, Germany 305
Testing effectiveness (Phase 2)Study completedNCT03311854
What this trial is testing

Investigate the Safety and Efficacy of Emapalumab, an Anti-IFN-gamma mAb in Patients With Systemic Juvenile Idiopathic Arthritis (sJIA) or Adult-onset Still's Disease (AOSD) Developing Macrophage Activation Syndrome/Secondary HLH (MAS/sHLH)

Who this might be right for
Macrophage Activation SyndromeLymphohistiocytosis, HemophagocyticArthritis, Juvenile+1 more
Swedish Orphan Biovitrum 14
Post-approval studies (Phase 4)Study completedNCT00491179
What this trial is testing

Retreatment of Dialysis Patients With Chronic Hepatitis C With Pegylated Interferon Alfa-2a Plus Low Dose Ribavirin

Who this might be right for
Chronic Hepatitis CHemodialysis
National Taiwan University Hospital 35
Large-scale testing (Phase 3)Study completedNCT00099502
What this trial is testing

BEYOND: Betaferon/Betaseron Efficacy Yielding Outcomes of a New Dose in Multiple Sclerosis (MS) Patients

Who this might be right for
Multiple Sclerosis, Relapsing-Remitting
Bayer 2,244
Large-scale testing (Phase 3)Study completedNCT00001729
What this trial is testing

Combination Drug Therapy for Patients With Hepatitis C

Who this might be right for
Chronic Hepatitis CFibrosisHemolytic Anemia
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) 120
Not applicableStudy completedNCT01233245
What this trial is testing

BetaPlus Survey - Observational Study to Assess Drug Adherence in Patients With Multiple Sclerosis After Conversion to Betaferon® by Using Elements of the BetaPlus Program

Who this might be right for
Relapsing Remitting MS (RRMS)Secondary Progressive MS (SPMS)
Bayer 1,077
Next Page